Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...

This cohort study found that key sociodemographic, health care, and clinical factors are associated with receipt of semaglutide, a novel glucagon-like peptide-1 (GLP-1) receptor agonist medication, in ...

Recent findings indicate that widely used weight-loss medications might lead to muscle loss, including vital heart muscle, ...

This cohort study found that key sociodemographic, health care, and clinical factors are associated with receipt of semaglutide, a ...

PEOPLE TAKING GLP-1S have a reduced risk of heart attacks, strokes, and death from cardiovascular disease, according to a ...

Also, “make sure your new diet is rich in muscle-building protein,” says Paul Titchenell, PhD, at the University of Pennsylvania. Yeah, ouch. A new study found that men who took semaglutide ...

Drugs targeting the glucagon-like peptide-1 receptor (GLP-1R ... three smaller biotechs - Viking Therapeutics, Altimmune, and Structure Therapeutics - are emerging as potential disrupters in ...